OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
6
Results
Show all
Save search
Copy query
Show results for
Unknown
(6)
Publication Date
Release Date
2018
(1)
2015
(1)
2014
(1)
2012
(1)
2011
(1)
2009
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Adjuvant ovarian suppression in premenopausal breast cancer.
Not available
S-EPMC4341825
|
biostudies-literature
Cite
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.
Not available
S-EPMC4175521
|
biostudies-literature
Cite
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.
Not available
S-EPMC6193457
|
biostudies-literature
Cite
The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause.
Not available
S-EPMC4802157
|
biostudies-literature
Cite
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up.
Not available
S-EPMC3235950
|
biostudies-literature
Cite
Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer.
Not available
S-EPMC2921823
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets